Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial (Q34625239)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial |
scientific article |
Statements
1 reference
Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial (English)
1 reference
J David Spence
1 reference
Catherine M Viscoli
1 reference
Walter N Kernan
1 reference
Silvio E Inzucchi
1 reference
Lawrence M Brass
1 reference
Robin Conwit
1 reference
Karen L Furie
1 reference
Mark Gorman
1 reference
Peter D Guarino
1 reference
Anne M Lovejoy
1 reference
Peter N Peduzzi
1 reference
David Tanne
1 reference
Antonio Carolei
1 reference
Gary A Ford
1 reference
Mark W Parsons
1 reference
Peter A Ringleb
1 reference
Gregory G Schwartz
1 reference
Lawrence H Young
1 reference
IRIS Trial investigators
1 reference
28 July 2014
1 reference
1 reference
168
1 reference
6
1 reference
823-9.e6
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference